NORTHEAST INVESTMENT MANAGEMENT - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHEAST INVESTMENT MANAGEMENT ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,752,970
-4.5%
27,027
-5.4%
0.16%
-0.6%
Q2 2023$2,883,402
+9.9%
28,574
+0.2%
0.16%
+2.5%
Q1 2023$2,623,840
+101089.4%
28,520
-0.2%
0.16%
-3.6%
Q4 2022$2,593
-99.9%
28,584
-3.0%
0.16%
+8.6%
Q3 2022$2,240,000
-12.8%
29,475
-3.1%
0.15%
-7.3%
Q2 2022$2,570,000
-4.9%
30,405
-1.3%
0.16%
+15.5%
Q1 2022$2,702,000
-0.7%
30,795
-1.0%
0.14%
+6.8%
Q4 2021$2,721,000
-12.5%
31,106
-18.2%
0.13%
-19.9%
Q3 2021$3,109,000
-15.6%
38,012
-5.9%
0.17%
-16.2%
Q2 2021$3,685,000
+1.8%
40,387
-4.7%
0.20%
-7.5%
Q1 2021$3,621,000
-15.7%
42,362
-6.9%
0.21%
-18.0%
Q4 2020$4,297,000
+1.8%
45,504
-6.2%
0.26%
-6.8%
Q3 2020$4,219,000
-0.5%
48,517
-0.1%
0.28%
-11.7%
Q2 2020$4,240,000
+11.8%
48,545
+5.6%
0.32%
-8.9%
Q1 2020$3,791,000
-15.1%
45,980
-2.5%
0.35%
+5.8%
Q4 2019$4,466,000
+8.0%
47,160
-0.9%
0.33%
-0.3%
Q3 2019$4,134,000
-5.1%
47,572
-0.2%
0.33%
-4.6%
Q2 2019$4,354,000
-5.0%
47,681
+0.0%
0.35%
-10.1%
Q1 2019$4,584,000
+12.0%
47,680
-0.0%
0.38%
-2.3%
Q4 2018$4,092,000
-3.7%
47,689
-3.3%
0.39%
+16.2%
Q3 2018$4,249,000
-5.1%
49,319
-16.8%
0.34%
-10.6%
Q2 2018$4,476,000
-13.4%
59,257
-7.3%
0.38%
-17.1%
Q1 2018$5,166,000
-3.0%
63,894
+0.8%
0.46%
+2.2%
Q4 2017$5,324,000
-2.3%
63,407
-0.1%
0.45%
-7.5%
Q3 2017$5,452,000
+2.3%
63,502
-0.5%
0.48%
-0.4%
Q2 2017$5,330,000
+6.6%
63,852
-5.2%
0.48%
+3.4%
Q1 2017$5,002,000
-22.1%
67,354
-23.6%
0.47%
-23.9%
Q4 2016$6,419,000
-30.7%
88,131
-24.9%
0.62%
-33.4%
Q3 2016$9,262,000
-19.9%
117,300
-16.2%
0.92%
-20.4%
Q2 2016$11,556,000
-19.0%
140,052
-28.9%
1.16%
-20.7%
Q1 2016$14,260,000
-22.8%
196,856
-8.4%
1.46%
-23.7%
Q4 2015$18,482,000
-5.7%
214,809
+0.8%
1.92%
-9.3%
Q3 2015$19,597,000
-7.6%
213,196
-1.2%
2.12%
-1.3%
Q2 2015$21,214,000
-1.2%
215,724
-1.0%
2.14%
+1.7%
Q1 2015$21,479,000
+4.4%
217,819
-1.9%
2.11%
+5.0%
Q4 2014$20,564,000
-0.8%
221,928
+0.7%
2.01%
-3.6%
Q3 2014$20,735,000
+5.5%
220,282
+1.5%
2.08%
+5.6%
Q2 2014$19,647,000
+6.3%
217,026
-0.2%
1.97%
+0.3%
Q1 2014$18,490,000
+4.6%
217,484
-1.1%
1.97%
-0.5%
Q4 2013$17,674,000
+5.1%
219,876
+0.3%
1.98%
-3.1%
Q3 2013$16,816,000
+10.2%
219,209
+1.5%
2.04%
+4.2%
Q2 2013$15,265,000215,8751.96%
Other shareholders
NOVARTIS A G shareholders Q3 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders